FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA) since 2004. Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Vosevi (sofosbuvir, velpatasvir and voxilaprevir) - July 18, 2017
- Nerlynx (neratinib) - July 17, 2017
- Tremfya (guselkumab) - July 13, 2017
- Endari (L-glutamine) - July 07, 2017
- Triptodur (triptorelin) - June 29, 2017
- Bevyxxa (betrixaban) - June 23, 2017
- Haegarda (C1 esterase inhibitor (human)) - June 22, 2017
- Rituxan Hycela (rituximab and hyaluronidase human) - June 22, 2017
- Mydayis (amphetamine mixed salts) - June 20, 2017
- Baxdela (delafloxacin) - June 19, 2017
- Cotempla XR-ODT (methylphenidate) - June 19, 2017
- Symjepi (epinephrine) - June 15, 2017
- Gleolan (aminolevulinic acid hydrochloride) - June 06, 2017
- Rebinyn (coagulation factor IX (recombinant), glycopegylated) - May 31, 2017
- Zerviate (cetirizine hydrochloride) - May 30, 2017
- Kevzara (sarilumab) - May 22, 2017
- Radicava (edaravone) - May 05, 2017
- Imfinzi (durvalumab) - May 01, 2017
- Alunbrig (brigatinib) - April 28, 2017
- Rydapt (midostaurin) - April 28, 2017
